摘要
目的探析盐酸利托君和硫酸镁在治疗先兆早产伴胎膜早破中的价值。方法在我院2015年2月~2017年3月产科收治的先兆早产伴胎膜早破患者中选取138例随机分成A组和B组,A组患者给予盐酸利托君保胎,B组患者选择硫酸镁保胎,对比两组患者的孕周延长时间、新生儿状况等。结果 A组孕妇在孕周延长时间、宫缩抑制时间优于B组,且A组孕妇的药物不良反应发生率低于B组孕妇,P<0.05;A组新生儿的存活率比B组高,且A组存活新生儿出生5min的Apgar评分高于B组,P<0.05。结论盐酸利托君治疗先兆早产伴胎膜早破效果确切,能延长患者的孕周,提高新生儿存活率,值得推广。
Objective To explore the value of Ritodrine hydrochloride and Magnesium Sulfate in the treatment of threatened preterm labor complicated with premature rupture of membranes. Methods 138 patients with threatened preterm labor complicated with premature rupture of membranes admitted in obstetrics department of our hospital from February 2015 to March 2017 were selected and randomly divided into group A and groupB. Patients in group A were treated with ritodrine hydrochloride treatment, and patients in group B were treated with Magnesium Sulfate tocolysis. Gestational age and neonatal condition of the two groups were compared. Results The gestational age and the time of uterine contraction suppression in the group A were better than those in the group B, and the incidence of adverse drug reactions in the group A was lower than that in the group B, and P 〈0.05. The survival rate of the neonates in group A was higher than that in group B, and the Apgar score of neonates born with 5rain in the group A was higher than that in the group B, and P 〈 0.05. Conclusion Ritodrine hydrochloride in the treatment of threatened premature labor with premature rupture of membranes is effective. It can prolong gestational age, improve the neonatal survival rate, and it is worthy of promotion.
出处
《中国医药科学》
2017年第18期46-48,共3页
China Medicine And Pharmacy
关键词
盐酸利托君
硫酸镁
先兆早产
胎膜早破
新生儿
APGAR评分
Ritodrine hydrochloride
Magnesium sulphate
Threatened preterm labor
Premature rupture of fetal membranes
Newborn
Apgar score
